[go: up one dir, main page]

RU2007103125A - Масло эму и фруктовый состав - Google Patents

Масло эму и фруктовый состав Download PDF

Info

Publication number
RU2007103125A
RU2007103125A RU2007103125/15A RU2007103125A RU2007103125A RU 2007103125 A RU2007103125 A RU 2007103125A RU 2007103125/15 A RU2007103125/15 A RU 2007103125/15A RU 2007103125 A RU2007103125 A RU 2007103125A RU 2007103125 A RU2007103125 A RU 2007103125A
Authority
RU
Russia
Prior art keywords
composition according
emu oil
fruits
well
weight
Prior art date
Application number
RU2007103125/15A
Other languages
English (en)
Inventor
Раймонд М. ПЛЕВА (US)
Раймонд М. ПЛЕВА
Original Assignee
Раймонд М. ПЛЕВА (US)
Раймонд М. ПЛЕВА
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Раймонд М. ПЛЕВА (US), Раймонд М. ПЛЕВА filed Critical Раймонд М. ПЛЕВА (US)
Publication of RU2007103125A publication Critical patent/RU2007103125A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Birds (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)

Claims (11)

1. Состав, содержащий масло эму и переработанные фрукты.
2. Состав по п.1, отличающийся тем, что указанные переработанные фрукты выбирают из группы, включающей чернику, гранат, сливы, клюкву, черноплодную аронию, вишни и черноплодную бузину.
3. Состав по п.2, отличающийся тем, что указанные переработанные фрукты представляют собой цельную вишню.
4. Состав по п.3, отличающийся тем, что указанная вишня представляет собой кислую вишню.
5. Состав по п.1, содержащий по весу от 1 до 20% масла эму, а также от 2 до 15% фруктов.
6. Состав по п.2, содержащий по весу от 1 до 20% масла эму, а также от 2 до 15% фруктов.
7. Состав по п.3, содержащий по весу от 1 до 20% масла эму, а также от 2 до 15% фруктов.
8. Состав по п.4, содержащий по весу от 1 до 20% масла эму, а также от 2 до 15% фруктов.
9. Состав по пп.1-8 в любой из следующих форм: кремы, пилюли, желатиновые капсулы, масла для массажа, лосьоны, гели, шампуни, мыла, кондиционеры, спреи, твердые вещества и порошки.
10. Состав по п.9, содержащий от 1 до 35% масла эму, а также от 1 до 45% вишни.
11. Состав, содержащий масло эму, а также одно вещество, экстрагированное из цельных вишен, отличающийся тем, что указанное вещество является веществом из группы, включающей антоцианины, мелатонины, фенольные смолы и флаваноиды.
RU2007103125/15A 2004-07-28 2005-07-28 Масло эму и фруктовый состав RU2007103125A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US52196504P 2004-07-28 2004-07-28
US60/521,965 2004-07-28
US59385205P 2005-02-18 2005-02-18
US60/593,852 2005-02-18

Publications (1)

Publication Number Publication Date
RU2007103125A true RU2007103125A (ru) 2008-09-10

Family

ID=35787823

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007103125/15A RU2007103125A (ru) 2004-07-28 2005-07-28 Масло эму и фруктовый состав

Country Status (9)

Country Link
US (2) US20080057116A1 (ru)
EP (1) EP1771185A4 (ru)
JP (1) JP2008508301A (ru)
CN (1) CN101065132A (ru)
AU (1) AU2005269382A1 (ru)
CA (1) CA2574968C (ru)
MX (1) MX2007001098A (ru)
RU (1) RU2007103125A (ru)
WO (1) WO2006015119A2 (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2631152T3 (es) 2004-01-22 2017-08-28 University Of Miami Formulaciones de coenzima Q10 tópicas o intravenosas para su uso en el tratamiento del cáncer
US20070196298A1 (en) * 2005-05-31 2007-08-23 Kostick Richard H Cosmetic and dermatological formulations with natural pigments and methods of use
US8987329B2 (en) * 2006-04-12 2015-03-24 Conopco, Inc. Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
JP2009538923A (ja) * 2006-06-01 2009-11-12 サクラ プロパティーズ、エルエルシー フコイダン組成物及び方法
US7494674B2 (en) 2006-09-22 2009-02-24 Lapointe Andrew T Nutraceutical with tart cherries and method of treatment therewith
EP2271325A4 (en) 2008-04-11 2011-11-09 Cytotech Labs Llc METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS
US10519504B2 (en) 2009-05-11 2019-12-31 Berg Llc Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
EP2694463B8 (en) 2011-04-04 2019-10-09 Berg LLC Treating central nervous system tumors with coenzyme q10
US9138446B2 (en) * 2011-06-08 2015-09-22 Scott Alan Weisenfluh EMU oil in combination with other active ingredients for treating skin imperfections
CN102389378B (zh) * 2011-11-23 2012-12-12 天津郁美净集团有限公司 一种用于化妆品的复合油脂微乳液及其制备方法
KR20150131302A (ko) * 2013-03-14 2015-11-24 3 인 1 덴탈 피엘엘씨 구강 건조증의 치료 및 치아 치료를 위한 조성물
EA032775B1 (ru) 2013-04-08 2019-07-31 Берг Ллк Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
WO2015035094A1 (en) 2013-09-04 2015-03-12 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10
CN106138717A (zh) * 2015-03-25 2016-11-23 张爱民 一种用于冰疗的药膏及其制备使用方法
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス/プレバイオティクス有効成分を含む清浄剤組成物
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US20190175680A1 (en) * 2016-09-07 2019-06-13 Nanosmart Fruit, Llc Compositions comprising nanoparticles derived from whole fruit
EP3544575A1 (en) 2016-11-23 2019-10-02 GOJO Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652007A (en) * 1992-12-01 1997-07-29 Pleva; Raymond M. Method of making a cured cherry-containing meat product
US5670200A (en) * 1992-12-01 1997-09-23 Pleva; Raymond M. Cherry-containing meat product and method of making the same
US6103246A (en) * 1993-06-03 2000-08-15 Tisdale; Carrie J. Creams and lotions containing emu oil
US5472713A (en) * 1994-11-23 1995-12-05 Elf Resources, Inc. Therapeutic uses of emu oil
US6133318A (en) * 1995-11-15 2000-10-17 Hart; Francis J. Oxalic acid or oxalate compositions and methods for bacterial, viral, and other diseases or conditions
DK0915693T3 (da) * 1996-08-02 2004-02-09 Plum Kemi Produktion As En olie-i-vand emulsion til brug på menneskers hud for at rengøre, beskytte eller forbedre hudens tilstand
AU7472398A (en) 1997-05-09 1998-11-27 Medlogic Global Corporation Compositions for cosmetic applications
WO2000026285A1 (en) 1998-10-29 2000-05-11 Penreco Gel compositions
US6881776B2 (en) * 1998-10-29 2005-04-19 Penreco Gel compositions
US6534086B1 (en) * 2000-03-06 2003-03-18 Metagenics, Inc. Composition and method for treatment of inflammation and pain in mammals
ATE270558T1 (de) * 1999-08-26 2004-07-15 Ganeden Biotech Inc Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
US7879824B2 (en) * 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US20030031724A1 (en) * 2001-05-16 2003-02-13 Frank Orthoefer Anti-inflammatory composition and method of using same
US20060073211A1 (en) * 2001-06-18 2006-04-06 Michael Marenick Cellulite formulation containing whole egg
US6773718B2 (en) * 2001-11-15 2004-08-10 3M Innovative Properties Company Oil absorbent wipe with rapid visual indication
US6579543B1 (en) * 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin
AUPS082102A0 (en) * 2002-03-01 2002-03-21 Women's And Children's Hospital Therapeutic properties of oils
AU2002950308A0 (en) * 2002-07-23 2002-09-12 Phoenix Eagle Company Pty Ltd Topically applied composition
US20050266064A1 (en) * 2004-05-29 2005-12-01 Mccarthy Kathryn J Cosmetic compositions and methods
US20080032032A1 (en) * 2006-08-01 2008-02-07 Pleva Raymond M Cherry-based additive
US7666859B2 (en) * 2006-09-08 2010-02-23 Norman Turkowitz Skin compositions containing hydrocortisone
US8623191B2 (en) * 2006-09-22 2014-01-07 Honeywell International Inc. Non-volatile addressable electronic paper with gray level capability

Also Published As

Publication number Publication date
MX2007001098A (es) 2009-02-11
CA2574968C (en) 2014-05-20
US7939107B2 (en) 2011-05-10
EP1771185A4 (en) 2009-09-23
JP2008508301A (ja) 2008-03-21
US20090258080A1 (en) 2009-10-15
WO2006015119A2 (en) 2006-02-09
CN101065132A (zh) 2007-10-31
CA2574968A1 (en) 2006-02-09
WO2006015119A3 (en) 2006-03-16
AU2005269382A1 (en) 2006-02-09
EP1771185A2 (en) 2007-04-11
US20080057116A1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
RU2007103125A (ru) Масло эму и фруктовый состав
Garavand et al. Different techniques for extraction and micro/nanoencapsulation of saffron bioactive ingredients
AU2016332405B2 (en) Olive leaf extract and method for producing same
EP2266529A3 (de) UV-Schutz-Kosmetikum
Na et al. Antioxidant compounds from the stem bark of Sorbus commixta
Quang Hop et al. Botanical description, traditional uses, phytochemistry, and pharmacology of the genus Artabotrys: a review
AR227149A1 (es) Un aparato para extraer aceite de la cascara de frutos citricos,no esfericos,enteros
RU97121228A (ru) Десерт
RU2000123799A (ru) Фиточай
Normala et al. Quantification of total phenolics in different parts of Pluchea indica (Less) ethanolic and water extracts
Lee et al. Identification of phenolic compounds and antioxidant effects from the exudate of germinating peanut (Arachis hypogaea)
EP2204161A3 (de) Kosmetische Zusammensetzung enthaltend ein Öl aus den Früchten, insbesondere den Kernen von Pflanzen der Ordnung Rosales
VESCAN et al. Several lipophilic components of five elite genotypes of Romanian seabuckthorn (Hippophae rhamnoides subs. carpatica)
WO2008035129A2 (en) The application of the oil fraction obtained from sour cherry (prunus cerasus) seed kernel
Osman et al. Antioxidant activity and phytochemical components of Jatropha curcas Linn. root extract
EA025244B1 (ru) Применение экстракта сосновой коры, содержащего этерифицированные процианидоловые олигомеры, для увеличения синтеза коллагена
Yang et al. Prospecting antioxidant capacities and health-enhancing phytonutrient contents of southern highbush blueberry wine compared to grape wines and fruit liquors
RU2005108698A (ru) Способ предохранения жиров и масел от окисления
RU2001134937A (ru) Ароматизированный фруктовый коктейль
Damian VALORIZATION OF MANGO BY-PRODUCTS: BIOLOGICAL ACTIVITES
Wasi et al. Extraction of Bioactive Compounds from Citrus Waste and Its Application: A Review
Biruk et al. Research Article In Vivo Antimalarial Activity of 80% Methanol and Aqueous Bark Extracts of Terminalia brownii Fresen.(Combretaceae) against Plasmodium berghei in Mice
Tchamgoue et al. Natural Resources for Human Health
Abdullah et al. Radical scavenging activity and total phenolic content of Gracilaria manilaensis extracts
RU2001109662A (ru) Способ получения водорастворимого и жирорастворимого концентратов каротиноидов из растительного сырья

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20091119